Hôpital de Hautepierre

The trials here

What the 16 trials at this site are about, from their registry records.

Conditions

• Childhood cancers3 trials
• Neuromyelitis optica (NMOSD)2 trials
• Ovarian cancer2 trials
• ALS (motor neurone disease)1 trial
• Epilepsy1 trial
• Huntington's disease1 trial
• Multiple myeloma1 trial
• Multiple sclerosis1 trial
• Parkinson disease1 trial
• Rheumatoid arthritis1 trial
• Sarcoma1 trial
• Stroke1 trial

Phase

• Phase 23 trials
• Phase 32 trials
• Phase 1/21 trial
• Phase 2/31 trial

Status

• Completed6 trials
• Not yet recruiting4 trials
• Recruiting3 trials
• Active, not recruiting1 trial
• Enrolling by invitation1 trial
• Withdrawn1 trial

Lead sponsor

• ARCAGY/ GINECO GROUP2 trials
• Gustave Roussy, Cancer Campus, Grand Paris2 trials
• University Hospital, Lille2 trials
• Ad scientiam1 trial
• Amzell1 trial
• and 8 more

Running trials

• Not yet recruiting

  Effectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour

  NCT07558395· Institut National de la Santé Et de la Recherche Médicale, France· Source

  Contact: Natacha Entz-Werle, Pr

• Recruiting

  Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse

  NCT07871864· Phase 3· Gustave Roussy, Cancer Campus, Grand Paris· Source

  Contact: Natacha ENTZ-WERLE, Pr

• Not yet recruiting

  Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer

  NCT07637851· Phase 1/2· ARCAGY/ GINECO GROUP· Source

  Contact: Laurianne EBERST (principal investigator)

• Recruiting

  EXOPULSE Suit and Walking Ability of Patients With Multiple Sclerosis

  NCT07252895· Otto Bock France SNC· Source

  Contact: Jérôme DE SEZE, Pr.

• Active, not recruiting

  Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients

  NCT06062537· Intergroupe Francophone du Myelome· Source

• Recruiting

  Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE)

  NCT05521776· Assistance Publique - Hôpitaux de Paris· Source

  Contact: Anne-Sophie WEINGERTNER, Dr

• Recruiting

  MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2

  NCT05691608· Gustave Roussy, Cancer Campus, Grand Paris· Source

  Contact: Natacha ENTZ-WERLE, Dr

• Recruiting

  Addition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT

  NCT04602377· Phase 2· ARCAGY/ GINECO GROUP· Source

  Contact: Lauriane EBERST (principal investigator)

• Enrolling by invitation

  Juvenile Inflammatory Rheumatism (JIR) Cohorte

  NCT02377245· Michaël Hofer· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers3 recruiting
• Ovarian cancer2 recruiting
• Multiple sclerosis1 recruiting
• Rheumatoid arthritis1 recruiting
• Sarcoma1 recruiting

Closed trials

• Completed

  A Trial to Assess the Efficacy and Safety of OTR4132-MD in Patients With Acute Ischemic Stroke

  NCT06700824· Phase 2· Organ, Tissue, Regeneration, Repair and Replacement· Source

• Recruiting

  Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

  NCT05566769· Ad scientiam· Source

  Contact: Dr Levy

• Withdrawn

  A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms

  NCT05128344· Phase 3· Amzell· Source

• Completed

  Efficacy and Safety on SOM3355 in Huntington's Disease Chorea

  NCT05475483· Phase 2· SOM Innovation Biotech SA· Source

• Completed

  In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMO

  NCT04629274· Imcyse SA· Source

• Completed

  Conservative Iron Chelation as a Disease-modifying Strategy in Amyotrophic Lateral Sclerosis

  NCT03293069· Phase 2/3· University Hospital, Lille· Source

• Completed

  Predictive Factors and Subthalamic Stimulation in Parkinson's Disease

  NCT02360683· University Hospital, Lille· Source